SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : ALTA NATURAL HERBS & SUPPLEMENTS LTD. (AHS-ASE) -- Ignore unavailable to you. Want to Upgrade?


To: Robert G. Hanah who wrote (31)11/12/1998 9:20:00 AM
From: Mr Metals  Read Replies (1) | Respond to of 66
 
****NEWS RELEASE****

Alta Natural Herbs & Supplements Ltd -
Results from Hepatico trials to be released
Alta Natural Herbs & Supplements Ltd AHS
Shares issued 14,391,333 1998-11-11 close $0.9
Thursday Nov 12 1998

Mr. Adolph Huckschlag reports
Results from clinical and preclinical trials done on Alta Natural's Hepatitis-C product, Hepatico, will be released at press conferences in Vancouver (Nov. 16) and Seattle (Nov. 17).
The company will be releasing the results of 17 clinical and preclinical trials conducted in Europe on the efficacy of Hepatico in the treatment of serious liver disease including Hepatitis-C. In addition, the company will release the preliminary results of its non-clinical test currently under way in North America. The summary results will also be released worldwide via the company's Internet site at www.alta-natural.com.
Due to sheer size of and demand for the trial material, anyone, including members of the media, are required to RSVP the company to ensure availability of all support material. Only those who RSVP prior to the press conferences can be guaranteed full documentation.

(c) Copyright 1998 Canjex Publishing Ltd. canada-stockwatch.com

MM